Predictive Models for Cardiotoxicity Risk
AI Tools Protect Hearts of Older Breast Cancer Patients
The CARDIOCARE project announces AI models to predict cardiotoxicity risks within one year of cancer treatment.
A digital screen displaying a 3D heart model with data graphs and a doctor using a tablet in a modern medical facility.
Photo: Avantgarde News
The EU-funded CARDIOCARE project has introduced AI-powered tools to monitor heart health in older breast cancer patients [1]. Researchers utilized multimodal datasets to develop models that predict cardiotoxicity risks within one year of beginning treatment [1].
These advancements aim to identify patients at high risk of heart damage from cancer therapies [1]. The project recently presented these findings through the European Society of Cardiology to highlight improved monitoring strategies [1].
By integrating diverse data sources, the AI tools provide a more comprehensive view of patient health [1]. This approach allows medical teams to intervene early and adjust treatments to safeguard the cardiovascular system [1].
Editorial notes
Transparency note
AI assisted drafting. Human edited and reviewed.
- AI assisted
- Yes
- Human review
- Yes
- Last updated
Risk assessment
The story relies on a single source domain (escardio.org), failing the recommendation for three independent domains.
Sources
Related stories
View all
Topics
About the author
Avantgarde News Desk covers predictive models for cardiotoxicity risk and editorial analysis for Avantgarde News.